Market Tracker

03/30 4:22pm ET

Rexahn Pharmaceuticals Inc (NYSE MKT LLC:RNN)

0.482
Delayed Data
As of 4:02pm ET
 +0.002 / +0.42%
Today’s Change
0.13
Today|||52-Week Range
0.56
+239.68%
Year-to-Date

Today’s Trading

Previous close0.48
Today’s open0.48
Day’s range0.47 - 0.48
Volume1,803,850
Average volume (3 months)3,246,200
Market cap$114.0M
Dividend yield--
Data as of 4:02pm ET, 03/30/2017

Growth & Valuation

Earnings growth (last year)+50.00%
Earnings growth (this year)-75.00%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book6.68

Competitors

 Today’s
change
Today’s
% change
PRQRProQR Therapeutics N...+0.20+4.12%
CPIXCumberland Pharmaceu...+0.02+0.29%
VVUSVIVUS Inc-0.02-1.80%
--Innovative Pharmaceu...+0.00+1.37%
Data as of 4:00pm ET, 03/30/2017

Financials

Next reporting dateMay 15, 2017
EPS forecast (this quarter)-$0.02
Annual revenue (last year)$0.00
Annual profit (last year)-$9.3M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Peter David Suzdak
Chief Financial Officer, Secretary &
Senior VP
Tae Heum Jeong
Corporate headquarters
Rockville, Maryland

Forecasts